Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AND017 for Anemia in Non-Dialysis-Dependent Chronic Kidney Disease
NCT07487727Phase 3Recruiting
- Sponsor
- Kind Pharmaceuticals LLC
- Start
- Dec 2025
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of AND017 in anemia, sponsored by Kind Pharmaceuticals LLC. Started Dec 2025; status: recruiting.
02
Drugs
AND017
03
Conditions
anemia
Beyond the preview
Go deeper on NCT07487727.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07487727.